News
-
-
-
-
-
-
PRESS RELEASE
Medios AG continues its growth trajectory in the first half of 2024 and records disproportionately high increase in earnings
Medios AG continues its growth trajectory in the first half of 2024, with revenue up by 6.3% and EBITDA pre1 by 7.3%. Successful acquisition of Ceban and optimistic outlook for 2024 -
-
PRESS RELEASE
Medios expands „Advanced Therapies“ field and appoints Dr. Andreas Schmiede as Vice President
Medios AG strengthens activities in Advanced Therapies field, appoints Dr. Andreas Schmiede as Vice President. Focus on personalized medicine innovations and patient access to cutting-edge therapies -
-
